BGM Competitors & Alternatives
Compare BGM Group Ltd. Class A Ordinary Shares with similar stocks in the same industry
Pharmaceutical Preparations
BGM
Main Stock$0.34
Tradestie Score
53
Market Cap
$2.05B
Revenue Growth
0.1%
Top Competitors
553 stocks in Pharmaceutical Preparations| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
LLY
Eli Lilly & Co.
|
$922.50
|
$739.95B | 40.6 | 60 | Compare |
|
JNJ
Johnson & Johnson
|
$240.10
|
$448.07B | 21.6 | 56 | Compare |
|
ABBV
ABBVIE INC.
|
$210.26
|
$431.71B | 87.1 | 59 | Compare |
|
NVO
Novo-Nordisk A/S
|
$39.32
|
$262.92B | 10.6 | 61 | Compare |
|
AZN
AstraZeneca PLC
|
$204.38
|
$261.56B | 31.0 | 60 | Compare |
|
NVS
Novartis AG
|
$153.38
|
$254.99B | 21.6 | 62 | Compare |
|
ABT
Abbott Laboratories
|
$101.05
|
$232.30B | 27.1 | 63 | Compare |
|
MRK
Merck & Co., Inc.
|
$119.96
|
$225.13B | 16.5 | 63 | Compare |
|
PFE
Pfizer Inc.
|
$27.11
|
$154.70B | 20.1 | 60 | Compare |
|
SNY
Sanofi American Depositary Shares (Each representing one-half of one ordinary share)
|
$47.64
|
$121.27B | 19.9 | 61 | Compare |
More BGM Analysis
Data updated: Apr 15, 2026 | Industry: Pharmaceutical Preparations (SIC 2834)
553 stocks in this industry